Back to Search

STEVEN MCAFEE, MD

MD

Medical Oncology Physician

NPI: 1588647945IndividualAccepts Medicare

Specialties, Licenses & Credentials

Internal Medicine Physician

Internal Medicine

Code: 207R00000X

78170(MA)
Hematology & Oncology Physician

Internal Medicine — Hematology & Oncology

Code: 207RH0003X

78170(MA)
Medical Oncology PhysicianPrimary

Internal Medicine — Medical Oncology

Code: 207RX0202X

78170(MA)

CMS Specialties

PrimaryHEMATOLOGY/ONCOLOGY

Education

TUFTS UNIVERSITY SCHOOL OF MEDICINE

Class of 1987

Research & Publications (20)

Dose-escalated total body irradiation and autologous stem cell transplantation for refractory hematologic malignancy.
PMID 12007954·Int J Radiat Oncol Biol Phys·2002
3-trial
A proposed role for the psychiatrist in the treatment of adolescents with type I diabetes.
PMID 19408118·Psychiatr Q·2009
6-review
High-resolution HLA matching in double-umbilical-cord-blood reduced-intensity transplantation in adults.
PMID 19159415·Transfusion·2009
3-trial
Dosimetric comparison of three different treatment techniques in extensive scalp lesion irradiation.
PMID 18954915·Radiother Oncol·2009
5-case
Autologous SCT with a dose-reduced BU and CY regimen in older patients with non-Hodgkin's lymphoma.
PMID 18794868·Bone Marrow Transplant·2009
8-other
Clinical outcomes of late rather than early full-donor chimerism in patients with advanced lymphomas receiving nonmyeloablative allogeneic hematopoietic SCT.
PMID 18587439·Bone Marrow Transplant·2008
3-trial
Phase I and pharmacokinetic study of bortezomib in combination with idarubicin and cytarabine in patients with acute myelogenous leukemia.
PMID 18316568·Clin Cancer Res·2008
3-trial
Preinfusion variables predict the predominant unit in the setting of reduced-intensity double cord blood transplantation.
PMID 18037942·Bone Marrow Transplant·2008
3-trial
Regulatory T-cell recovery in recipients of haploidentical nonmyeloablative hematopoietic cell transplantation with a humanized anti-CD2 mAb, MEDI-507, with or without fludarabine.
PMID 17588483·Exp Hematol·2007
8-other
Phase I trial of parathyroid hormone to facilitate stem cell mobilization.
PMID 17580262·Biol Blood Marrow Transplant·2007
3-trial
Comparison of outcomes after transplantation of peripheral blood stem cells versus bone marrow following an identical nonmyeloablative conditioning regimen.
PMID 17468773·Bone Marrow Transplant·2007
3-trial
Double unrelated reduced-intensity umbilical cord blood transplantation in adults.
PMID 17222756·Biol Blood Marrow Transplant·2007
3-trial
Myeloma responses and tolerance following combined kidney and nonmyeloablative marrow transplantation: in vivo and in vitro analyses.
PMID 16796719·Am J Transplant·2006
8-other
Anti-tumour response despite loss of donor chimaerism in patients treated with non-myeloablative conditioning and allogeneic stem cell transplantation.
PMID 15667537·Br J Haematol·2005
3-trial
NK cell recovery, chimerism, function, and recognition in recipients of haploidentical hematopoietic cell transplantation following nonmyeloablative conditioning using a humanized anti-CD2 mAb, Medi-507.
PMID 14550807·Exp Hematol·2003
8-other
Early host CD8 T-cell recovery and sensitized anti-donor interleukin-2-producing and cytotoxic T-cell responses associated with marrow graft rejection following nonmyeloablative allogeneic bone marrow transplantation.
PMID 12842706·Exp Hematol·2003
8-other
Nonmyeloablative bone marrow transplantation: Infectious complications in 65 recipients of HLA-identical and mismatched transplants.
PMID 12813445·Biol Blood Marrow Transplant·2003
4-observational
Ground one.
PMID 12809369·Bull Menninger Clin·2003
8-other
Nonmyeloablative haploidentical stem-cell transplantation using anti-CD2 monoclonal antibody (MEDI-507)-based conditioning for refractory hematologic malignancies.
PMID 12777868·Transplantation·2003
8-other
Impact of prophylactic donor leukocyte infusions on mixed chimerism, graft-versus-host disease, and antitumor response in patients with advanced hematologic malignancies treated with nonmyeloablative conditioning and allogeneic bone marrow transplantation.
PMID 12766882·Biol Blood Marrow Transplant·2003
3-trial

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
100 BLOSSOM STREET, HEMATOLOGY ONCOLOGY ASSOCIATES COX6
BOSTON, MA 02114

Location

Practice Location

100 BLOSSOM STREET, BOSTON, MA
(617) 724-1124

Quick Facts

NPI
1588647945
Entity Type
Individual
Gender
Male
Medicare
Accepted
Specialties
3
Locations
1
Years in Practice
39
Publications
20

Are you this provider?

Claim Your Profile